Detalhe da pesquisa
1.
Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans.
Oncologist
; 28(6): e473-e477, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084789
2.
Multimodality Therapies for Localized Prostate Cancer.
Curr Oncol Rep
; 25(3): 221-229, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723856
3.
Selecting the optimal radiation modality in prostate cancer.
Clin Adv Hematol Oncol
; 21(9): 494-501, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647496
4.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051385
5.
Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting.
Eur J Nucl Med Mol Imaging
; 49(3): 1041-1051, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463809
6.
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
Eur J Nucl Med Mol Imaging
; 48(2): 501-508, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808077
7.
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol.
BMC Cancer
; 21(1): 512, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962579
8.
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
BMC Cancer
; 21(1): 538, 2021 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975579
9.
Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].
BMC Cancer
; 19(1): 97, 2019 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665383
10.
Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].
BMC Cancer
; 19(1): 18, 2019 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30616601
11.
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease.
BMC Cancer
; 19(1): 291, 2019 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935383
12.
Treatment of the primary tumor in metastatic prostate cancer.
World J Urol
; 37(12): 2597-2606, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30456709
13.
In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer".
Oncologist
; 28(11): e1129-e1130, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706534
14.
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
JAMA
; 319(9): 896-905, 2018 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509865
15.
Antitumor activity of a pyrrole-imidazole polyamide.
Proc Natl Acad Sci U S A
; 110(5): 1863-8, 2013 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23319609
16.
Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide.
Proc Natl Acad Sci U S A
; 109(40): 16041-5, 2012 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22988074
17.
Optimal patient selection for stereotactic body radiotherapy.
Lancet Oncol
; 20(12): e661, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31797787
18.
Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial.
Int J Radiat Oncol Biol Phys
; 118(5): 1181-1191, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160916
19.
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial.
Eur Urol
; 85(6): 517-520, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494380
20.
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial).
J Nucl Med
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664019